TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Problems

Heavy menstrual bleeding in adolescence

Key Statistics

  • 4.8–37% — Prevalence of HMB in adolescence
  • 50% — Anovulatory cycles in 1ST year post-menarche
  • 47% — MBL reduction with tranexamic acid

Don't-miss facts

  1. Admit if bleeding heavily, haemodynamically compromised, or Hb <80 g/dl (children’s unit if under 16)

  2. Tranexamic acid first line: 500–1000 mg TDS × up to 4 days (12–17y: 1 g TDS, max 4 g/day) – reduces loss by 47%

  3. First-line COCP EE 30 mcg + levonorgestrel 150 mcg; 70–80% amenorrhoea at 1 year if continuous

  4. Enzyme inducers (incl. topiramate >200 mg/day) → use LNG-IUS or DMPA. Implant not licensed <18 and not a HMB treatment

  5. Acute HMB: packed red cells first line; platelets if <50; oral progestogen (MPA 20 mg TDS) is usual UK first line – standard-dose CHC, not high dose

  6. Oral iron for deficiency: elemental iron 3–6 mg/kg (max 200 mg)/day in 2–3 divided doses

  7. Norethisterone → metabolised to ethinylestradiol → ↑VTE risk; prefer medroxyprogesterone where CHC contraindicated for VTE

  8. Sexual history always taken without the caregiver; chaperone mandatory for any examination; balance confidentiality against safeguarding

Screen for a bleeding disorder if…

HMB from menarche Recurrent epistaxis Excessive bruising Prolonged bleeding post injury/surgery Family history

Anaemia Failure of hormonal therapy

Numbers to know

Menarche 12–13y · cycle 21–45d · period 2–7d ITP = 7% of adolescent HMB PCOS 8–11% of adolescents

SLE: HMB in up to 50% Autoimmune thyroid disease 1 in 3500 children

LNG-IUS: 65% amenorrhoea/reduced loss at 12 months DMPA: 50–60% amenorrhoeic at 12mo, 70% at 24mo

Desogestrel 75 mcg: amenorrhoea in only ⅓–½ at 9–12 months

Abbreviation Key

  • HMB — heavy menstrual bleeding
  • VWD / vWF — von Willebrand disease / factor
  • HPO axis — hypothalamic–pituitary–ovarian axis
  • PCOS — polycystic ovary syndrome
  • NICE — National Institute for Health and Care Excellence
  • ITP — immune thrombocytopenia
  • BritSPAG — British Society for Paediatric and Adolescent
  • SLE — systemic lupus erythematosus Gynaecology
  • CHC / COCP — combined hormonal contraception / combined oral
  • UKMEC — UK Medical Eligibility Criteria for Contraceptive Use contraceptive pill
  • DMPA — depot medroxyprogesterone acetate
  • PT / aPTT — prothrombin / activated partial thromboplastin time

Source: Walter SL, Channing S, Crouch NS. Heavy menstrual bleeding in adolescence: who to investigate and how to manage it. The Obstetrician & Gynaecologist 2024;26:84–94. doi:10.1111/tog.12924

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free